TNF and sarcoidosis: Another study reported that 90 patients receiving different anti-TNF-a therapies (etanercept: 59%, adalimumab: 23% and infliximab:18%) all developed sarcoidosis-like lesions which was attributed to anti-TNF-a therapy [17].